CureVac NV
NASDAQ:CVAC

Watchlist Manager

CureVac NV

NASDAQ:CVAC

Watchlist

Dividends

Price: 2.74 USD -1.08% Market Closed

Market Cap: 614.6m USD

Have any thoughts about
CureVac NV?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

Add Price Alert

Price Target:

Last Price: 2.74 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

CVAC Alert

CureVac NV

2.74

-0.03 (-1.08%)

52 Week Range	2.31 6.12
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

CureVac NV

What unique competitive advantages
does CureVac NV hold over its rivals?

What risks and challenges
does CureVac NV face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of CureVac NV.

What unique competitive advantages
does CureVac NV hold over its rivals?

What risks and challenges
does CureVac NV face in the near future?

Summarize the latest earnings call
of CureVac NV.

What significant events have occurred
in CureVac NV over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CureVac NV.

Provide P/S
for CureVac NV.

Provide P/E
for CureVac NV.

Provide P/OCF
for CureVac NV.

Provide P/FCFE
for CureVac NV.

Provide P/B
for CureVac NV.

Provide EV/S
for CureVac NV.

Provide EV/GP
for CureVac NV.

Provide EV/EBITDA
for CureVac NV.

Provide EV/EBIT
for CureVac NV.

Provide EV/OCF
for CureVac NV.

Provide EV/FCFF
for CureVac NV.

Provide EV/IC
for CureVac NV.

Show me price targets
for CureVac NV made by professional analysts.

What are the Revenue projections
for CureVac NV?

How accurate were the past Revenue estimates
for CureVac NV?

What are the Net Income projections
for CureVac NV?

How accurate were the past Net Income estimates
for CureVac NV?

What are the EPS projections
for CureVac NV?

How accurate were the past EPS estimates
for CureVac NV?

What are the EBIT projections
for CureVac NV?

How accurate were the past EBIT estimates
for CureVac NV?

Compare the revenue forecasts
for CureVac NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CureVac NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CureVac NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of CureVac NV compared to its peers.

Compare the P/E ratios
of CureVac NV against its peers.

Discuss the investment returns and shareholder value creation
comparing CureVac NV with its peers.

Analyze the financial leverage
of CureVac NV compared to its main competitors.

Show all profitability ratios
for CureVac NV.

Provide ROE
for CureVac NV.

Provide ROA
for CureVac NV.

Provide ROIC
for CureVac NV.

Provide ROCE
for CureVac NV.

Provide Gross Margin
for CureVac NV.

Provide Operating Margin
for CureVac NV.

Provide Net Margin
for CureVac NV.

Provide FCF Margin
for CureVac NV.

Show all solvency ratios
for CureVac NV.

Provide D/E Ratio
for CureVac NV.

Provide D/A Ratio
for CureVac NV.

Provide Interest Coverage Ratio
for CureVac NV.

Provide Altman Z-Score Ratio
for CureVac NV.

Provide Quick Ratio
for CureVac NV.

Provide Current Ratio
for CureVac NV.

Provide Cash Ratio
for CureVac NV.

What is the historical Revenue growth
over the last 5 years for CureVac NV?

What is the historical Net Income growth
over the last 5 years for CureVac NV?

What is the current Free Cash Flow
of CureVac NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for CureVac NV.

EV/GP
Enterprise Value to Gross Profit

0.2

Current

-11.2

Median

Industry

Higher than median

Lower than industry value

All Countries

Forward Multiples

			Market Cap	EV/GP
DE		CureVac NV NASDAQ:CVAC	614.7m USD	0.2
FR		Pharnext SCA OTC:PNEXF	6T USD	0
US		Abbvie Inc NYSE:ABBV	320.1B USD	9.9
US		Amgen Inc NASDAQ:AMGN	150.5B USD	10.1
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	120.4B USD	12.3
US		Gilead Sciences Inc NASDAQ:GILD	113.8B USD	4.9
US	E	Epizyme Inc F:EPE	94.1B EUR	2 469.1
AU		CSL Ltd ASX:CSL	135.4B AUD	12.7
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	82.9B USD	6.3
US	S	Seagen Inc F:SGT	39.3B EUR	23.1
NL		argenx SE XBRU:ARGX	34.5B EUR	19.1


DE		CureVac NV NASDAQ:CVAC	Average EV/GP: 256.8 0.2
FR		Pharnext SCA OTC:PNEXF	Not Available
US		Abbvie Inc NYSE:ABBV	9.9
US		Amgen Inc NASDAQ:AMGN	10.1
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	12.3
US		Gilead Sciences Inc NASDAQ:GILD	4.9
US	E	Epizyme Inc F:EPE	2 469.1
AU		CSL Ltd ASX:CSL	12.7
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	6.3
US	S	Seagen Inc F:SGT	23.1
NL		argenx SE XBRU:ARGX	19.1

EV/GP Forward Multiples

Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/GP

N/A

2-Years Forward

EV/GP

N/A

3-Years Forward

EV/GP

N/A

CureVac NV
NASDAQ:CVAC

EV/GP
Enterprise Value to Gross Profit

EV/GP Forward Multiples

See Also

Company

Help

Tools

Stocks

CureVac NV NASDAQ:CVAC

EV/GP Enterprise Value to Gross Profit

EV/GP Forward Multiples

See Also

Company

Help

Tools

Stocks

CureVac NV
NASDAQ:CVAC

EV/GP
Enterprise Value to Gross Profit